Results 151 to 160 of about 5,590,035 (204)

Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades. [PDF]

Blood Adv
Olivieri D, Othus M, Vo P, Walter RB, Manjappa S, Basom R, Storb R, Keel S.   +7 more
europepmc   +1 more source

Correction to: An international survey of allogeneic hematopoietic cell transplantation for X-linked agammaglobulinemia. [PDF]

J Clin Immunol
Nishimura A, Uppuluri R, Raj R, Swaminathan VV, Cheng Y, Abu-Arja RF, Fu B, Laberko A, Albert MH, Hauck F, Bucciol G, Bigley V, Elcombe S, Kharya G, Pronk CJH, Wehr C, Neven B, Warnatz K, Meyts I, Morio T, Gennery AR, Kanegane H.   +21 more
europepmc   +1 more source

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation. [PDF]

Am J Hematol
Poiré X, Eikema DJ, Koster L, Kröger N, Maertens J, de Latour RP, Salmennieni U, Gedde-Dahl T, Yakoub-Agha I, Broers AEC, Passweg J, Castilla-Llorente C, Mieke S, Ceballos P, Drozd-Sokolowska J, Raj K, Scheid C, Gurnari C, Robin M, McLornan DP.   +19 more
europepmc   +1 more source

Interleukin-15 and innate effector cells as predictors of outcome in allogeneic hematopoietic cell transplantation. [PDF]

Front Immunol
Warny M, Ostrowski SR, Petersen SL, Friis LS, Kornblit BT, Andersen NS, Schjødt I, Larsen MH, Møller JA, Haastrup EK, Sengeløv H, Minculescu L.   +11 more
europepmc   +1 more source

CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial. [PDF]

Nat Med
DiPersio JF, Koehne G, Shah NN, Bernard L, Suh HC, Koura D, Tamari R, Mushtaq MU, Maakaron J, Rimando J, Kennedy VE, Patel SS, Hudson C, Loken MR, Slapak CA, Lloyd DM, Stanizzi DA, Lee-Sundlov MM, Thosar S, Mundelboim G, Guo G, Ge HG, Li BE, Xavier-Ferrucio J, Hyzy SL, Lin MI, Raffel GD, Cooper BW.   +27 more
europepmc   +1 more source

Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial). [PDF]

Ann Hematol
Giebel S, Czyż A, Hus I, Gil L, Giannopoulos K, Romejko-Jarosińska J, Majcherek M, Szeremet A, Wache A, Kwaśnik P, Swoboda R, Jurczak W.   +11 more
europepmc   +1 more source

Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Blood Cancer J
Li C, Tong H, Wang H, Ren Y, Qian J, Zhou X, Xu G, You L, Mao L, Meng H, Yu W, Ye X, Yang M, Huang J, Zhou, Xie W, Jin J, Lou Y.   +17 more
europepmc   +1 more source

Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation. [PDF]

J Infect Dis
Cheng GS, Campbell AP, Campbell AP, Xie H, Ogimi C, Waghmare A, Kuypers J, Nichols WG, Carpenter P, Corey L, Callais C, Sandmaier BM, Stevens-Ayers T, Jerome KR, Chien JW, Leisenring WM, Englund JA, Boeckh M.   +17 more
europepmc   +1 more source

How to Change the Role of Allogeneic Hematopoietic Cell Transplantation in Adults with B-Cell Acute Lymphoblastic Leukemia. [PDF]

Curr Issues Mol Biol
Canichella M, de Fabritiis P.
europepmc   +1 more source